LAMP1 and Platelet storage pool disease: Regarding mRNA levels of lysosomal-associated membrane protein 1 (LAMP1), our results showed that fibroblasts from sPD patients presented decreased LAMP1 mRNA levels, while AntiOxCIN4 treatment restored that parameter to control values (Fig. 4F).